SCHEMBL21708797

SCHEMBL21708797

CCCC(F)OC(=O)CC(c1ccccc1Cl)C(C)[N+](=O)[O-]

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.33
ALDH1A1 P00352 5/20 0.33
LMNA P02545 2/20 0.33
HTT P42858 3/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
RECQL P46063 1/20 0.33
UBE2M P61081 1/20 0.32
DCUN1D1 Q96GG9 1/20 0.32
TAS1R3 Q7RTX0 1/20 0.32
TAS1R1 Q7RTX1 1/20 0.32
KDM4E B2RXH2 3/20 0.31
GAA P10253 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21708717 0.84 CASP1 (0.36) CASP1ALDH1A1LMNAMAPTMEN1
SCHEMBL21632028 0.78 ADRB2 (0.35) CASP1ALDH1A1LMNAHTTCYP2D6
SCHEMBL21632073 0.77 CYP1A2 (0.47) LMNAMEN1KMT2ACYP1A2TSHR
SCHEMBL21708646 0.76 NISCH (0.37) CASP1ALDH1A1LMNAHTTMAPT
SCHEMBL21708675 0.75 CCR1 (0.37) CASP1ALDH1A1LMNAHTTMAPT
SCHEMBL21708736 0.71 ALDH1A1 (0.38) CASP1ALDH1A1CYP3A4CYP2D6TAS1R3
SCHEMBL21708509 0.70 NISCH (0.36) CASP1ALDH1A1HTTMEN1KMT2A
Hydrochloric Acid SCHEMBL21708570 0.70 NISCH (0.35) CASP1ALDH1A1HTTMEN1KMT2A
SCHEMBL21708512 0.70 CCR1 (0.36) CASP1ALDH1A1LMNAHTTMEN1
SCHEMBL3942717 0.68 HPGD (0.47) HTTMAPTMEN1KMT2ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed